| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.6M | +60.0% |
| Cost of Revenue | $8.1M | +34.0% |
| Gross Profit | $24.6M | +70.9% |
| R&D Expense | $673K | +16.2% |
| SG&A Expense | $11.3M | +30.8% |
| Operating Income | $5.4M | +1103.1% |
| Income Tax | $27K | +575.0% |
| Net Income | -$31.4M | -21.6% |
| EPS (Basic) | -$7.03 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.2M | +469.7% |
| Accounts Receivable | $3.3M | +0.5% |
| Inventory | $4.1M | +40.6% |
| Current Assets | $18.4M | +88.0% |
| Total Assets | $30.1M | +34.4% |
| Current Liabilities | $42.3M | -34.6% |
| Total Liabilities | $42.8M | -34.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.5M | +154.1% |
| Capital Expenditures | $490K | — |
| Investing Cash Flow | -$490K | -2433.3% |
| Financing Cash Flow | $6.4M | +21.9% |
| Free Cash Flow | $2.0M | +143.3% |
| — |
| EPS (Diluted) | -$7.03 | — |
| Stockholders' Equity |
| -$12.7M |
| +70.5% |